CORDIS · 266486 · FP7
NU-AGE New dietary strategies addressing the specific needs of elderly population for an healthy ageing in Europe
Coordinator: ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (IT)
NU-AGE is a large multidisciplinary consortium (30 partners, from 16 EU countries) involving nutritionists, biogerontologists, immunologists and molecular biologists from the most prestigious institutions in Europe, 5 large food industries, 8 traditional food companies and 1 biotech SME, SPES GEIE and FooDrinkEurope, covering the SME Food Industrial Associations of 13 European countries and the European Confederation the food and drink industry. NU-AGE aims are: 1. to counteract the physical/cognitive decline occurring in the elderly as a consequence of the progressive alteration of different…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €9.0M awarded to the consortium. The project runs over approximately 5 years from 2011-05-01 to 2016-04-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from IT
see all →- THCS — European Partnership on Transforming Health and Care Systems101095654 · HORIZON · €91.6M
- c4c — conect4children (COllaborative Network for European Clinical Trials For Children)777389 · H2020 · €67.0M
- ADITEC — Advanced Immunization Technologies280873 · FP7 · €30.0M
- ARCHETYPE SW550 — Demonstration of innovating parabolic solar trough using an alternative heat transfer fluid producing electricity and fresh water: ARChimede Hot Energy TYPology Enhanced Water Solar 550268181 · FP7 · €29.7M
- EPOS IP — EPOS Implementation Phase676564 · H2020 · €18.4M
- COMETHA — 80,000 TON/Y PRECOMMERCIAL INDUSTRIAL SCALE DEMONSTRATION PLANT ON SECOND GENERATION LIGNOCELLULOSIC ETHANOL322406 · FP7 · €17.9M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CP-IP funding scheme.
- What is the EU contribution?
- The European Commission contributes €9.0M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (IT).
- What is the project timeline?
- The project runs from 2011-05-01 to 2016-04-30 — approximately 5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 266486.